| Literature DB >> 22438731 |
Gonçalo Doria1, João Conde, Bruno Veigas, Leticia Giestas, Carina Almeida, Maria Assunção, João Rosa, Pedro V Baptista.
Abstract
In the last decade the use of nanomaterials has been having a great impact in biosensing. In particular, the unique properties of noble metal nanoparticles have allowed for the development of new biosensing platforms with enhanced capabilities in the specific detection of bioanalytes. Noble metal nanoparticles show unique physicochemical properties (such as ease of functionalization via simple chemistry and high surface-to-volume ratios) that allied with their unique spectral and optical properties have prompted the development of a plethora of biosensing platforms. Additionally, they also provide an additional or enhanced layer of application for commonly used techniques, such as fluorescence, infrared and Raman spectroscopy. Herein we review the use of noble metal nanoparticles for biosensing strategies--from synthesis and functionalization to integration in molecular diagnostics platforms, with special focus on those that have made their way into the diagnostics laboratory.Entities:
Keywords: DNA; RNA; antibody; biosensors; immunoassays; molecular diagnostics; nanotechnology; noble metal nanoparticles; nucleic acids; proteins
Mesh:
Year: 2012 PMID: 22438731 PMCID: PMC3304133 DOI: 10.3390/s120201657
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Types of conjugations between biomolecules and noble metal NPs.
- Very simple and straightforward to perform. | - Restricted to opposite charged biomolecules and NPs; - Very sensitive to environmental properties (e.g., pH, ionic strength, - Weak functionalization. | |
- Allows oriented functionalization; - Very robust functionalization. | - Requires NPs with capping agents with weaker adsorption than the derivatization moiety; - Usually requires modification of the biomolecule; - Subject to interference by other chemical groups available for adsorption within the biomolecule; - Affected by chemical degradation and surface oxidation of some NPs (e.g., silver). | |
- Allows oriented functionalization; - Very straightforward binding between affinity pairs. | - Requires modification of both NPs and biomolecules with an affinity pair; - Limited to availability of suitable binding affinity pairs. |
Figure 1.Example of LSPR modulation through different NP compositions. The LSPR absorption band of gold/silver alloy NPs increases to longer wavelengths with increasing amounts of gold.
Figure 2.Examples of different variations of cross-linking approaches for SERS. The schematics depicts different approaches to the use of Raman-active moieties to enhance SERS signal output via cross-linking strategies: the Raman-active moiety can be bond to the target (two illustrations to the left) or to the surface of the film and/or NP (two illustrations to the right). Signal enhancement will occur upon cross-linking of the involved moieties derived from target recognition and binding.
Figure 3.Different approaches for fluorescent-based noble metal NPs biosensing. (A) molecular nanobeacons and (B) other nanoprobes. Distance to the nanoparticle determine the fluorescence signal that is observed. Distances are not represented to the scale.
Summary of real biological samples tested with noble metal NP-based biosensors according to the type of NP and explored methodology principle.
| Colorimetric/scanometric | Gold | SNP (rs2131877) in human DNA [ Mutations in EGFR gene in genomic DNA [ SNP associated with long QT syndrome in genomic DNA [ SNPs in β-thalassemia gene in genomic DNA—mediated by PCR [ SNPs in MBL2 gene in genomic DNA—mediated by PCR [ Fusion genes in K562 cell line [ Hepatitis C virus RNA [ BCR-ABL fusion transcript in clinical samples [ FSY1 mRNA in total RNA [ |
| Gold | Melamine in whole milk [ Prostate specific antigen (PSA) in human serum [ CA15-3 breast cancer biomarker in human serum [ Genetically modified organisms [ Mutations associated to methicillin resistance in S. aureus & Factor V Leiden mutants [ | |
| Gold/silver alloy | TP53 gene [ BCR-ABL fusion genes [ | |
| NIR | Gold | Prostate cancer cells in mouse [ Lymph nodes in mouse [ Brain vessels in mouse [ HER2 cancer biomarker in breast adenocarcinoma cells [ |
| SERS | Gold | Nicotinic acid adenine dinucleotide phosphate (NAADP) in cell extracts [ Glucose in rat [ Multiple pathogen DNA in clinical specimens (cerebrospinal fluid, stool, pus, and sputum) [ Feline calicivirus (FCV) antibody from cell culture media [ Prostate-specific antigen in human serum [ Deep-tissue imaging in living mouse [ |
| Silver | HIV-1 DNA in genomic DNA - PCR mediated [ Glucose in rat [ | |
| Gold/silver core/shell | Phospholipase Cγ1 biomarker protein in cancer cells [ | |
| Fluorescence-based | Gold | |
| Silver | miRNA-486 expression levels in lung cancer cells [ Cell membrane imaging in cell lines [ | |
| Electric/Electrochemical | Gold | Factor V Leiden DNA mutation in genomic DNA – mediated by PCR [ |
| Gold | Anti- Human and mouse IgG antibody in human and mouse serum [ Interleukin-8 (IL-8) cancer biomarker in human serum [ Interleukin-6 (IL-6) cancer biomarker in calf serum [ Tumor necrosis factor α (TNF-α) in human serum [ Anti-hepatitis B virus antibodies and human IgG in human serum [ HIV-1 protease and inhibitors in human serum [ Human IgG in human serum [ Human and goat IgG in serum [ | |
| Silver | α-1-Fetoprotein (AFP) in human serum [ |